Healthcare Triangle's Subsidiary QuantumNexis Launches ZILOY in the U.S., A GenAI-Powered Integrative Mental Health Platform

Healthcare Triangle, Inc. (Nasdaq: HCTI), through its subsidiary QuantumNexis, has launched ZILOY in the U.S., a GenAI-powered integrative mental health platform designed to offer both hybrid and online care models. This launch comes at a time when over 60 million adults in the U.S. have experienced mental illness in the past year, with fewer than half receiving treatment, highlighting a significant gap in the current mental health care system.

ZILOY aims to bridge this gap by combining modern psychiatry, clinical psychology, therapeutic yoga, and clinical nutrition into a single platform powered by artificial intelligence and led by licensed clinicians. The platform is designed to provide personalized wellness journeys, addressing the needs of individuals and families across all life stages. With features like a comprehensive digital self-assessment and a multidisciplinary clinical team, ZILOY offers a dynamic, personalized care plan that evolves with the user's needs.

The platform also emphasizes security and scalability, with HIPAA-compliant architecture, end-to-end encryption, and secure cloud hosting. Healthcare Triangle and QuantumNexis highlight ZILOY's potential to improve behavioral health outcomes, reduce absenteeism and turnover, and decrease behavioral health claims, making it a valuable solution for employers, providers, and payers.

Suresh Venkatachari, Chairman of QuantumNexis, stated that ZILOY represents a significant step forward in their vision to reshape integrative mental health with GenAI. The platform is expected to be fully commercially available by Q4 2025, offering a scalable, tech-enabled solution to the current mental health care challenges.